Literature DB >> 7703859

A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.

D Bailey1, J B Cooper.   

Abstract

The aspartic proteinases are an important family of enzymes associated with several pathological conditions such as hypertension (renin), gastric ulcers (pepsin), neoplastic disease (cathepsins D and E), and AIDS (HIV proteinase). Studies of inhibitor binding are therefore of great importance for design of novel inhibitors for potential therapeutic applications. Numerous X-ray analyses have shown that transition-state isostere inhibitors of aspartic proteinases bind in similar extended conformations in the active-site cleft of the target enzyme. Upon comparison of 21 endothiapepsin inhibitor complexes, the hydrogen bond lengths were found to be shortest where the isostere (P1-P'1) interacts with the enzyme's catalytic aspartate pair. Hydrogen bonds with good geometry also occur at P'2, and more so at P3, where a conserved water molecule is involved in the interactions. Weaker interactions also occur at P2, where the side-chain conformations of the inhibitors appear to be more variable than at the more tightly held positions. At P2 and, to a lesser extent, P3, the side-chain conformations depend intriguingly on interactions with spatially adjacent side chains, namely P'1 and P1, respectively. The tight binding at P1-P'1, P3, and P'2 is also reflected in the larger number of van der Waals contacts and the large decreases in solvent-accessible area at these positions, as well as their low temperature factors. Our analysis substantiates earlier proposals for the locations of protons in the transition-state complex. Aspartate 32 is probably ionized in the complexes, its charge being stabilized by 1, or sometimes 2, hydrogen bonds from the transition-state analogues at P1. The detailed comparison also indicates that the P1 and P2 residues of substrate in the ES complex may be strained by the extensive binding interactions at P3, P'1, and P'2 in a manner that would facilitate hydrolysis of the scissile peptide bond.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7703859      PMCID: PMC2142641          DOI: 10.1002/pro.5560031126

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  32 in total

1.  Conformational preferences and the role of the statine residue in the crystal state.

Authors:  G Precigoux
Journal:  Biopolymers       Date:  1991-05       Impact factor: 2.505

2.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

3.  The interpretation of protein structures: estimation of static accessibility.

Authors:  B Lee; F M Richards
Journal:  J Mol Biol       Date:  1971-02-14       Impact factor: 5.469

4.  Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors.

Authors:  E A Lunney; H W Hamilton; J C Hodges; J S Kaltenbronn; J T Repine; M Badasso; J B Cooper; C Dealwis; B A Wallace; W T Lowther
Journal:  J Med Chem       Date:  1993-11-26       Impact factor: 7.446

5.  Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides.

Authors:  M N James; A R Sielecki; K Hayakawa; M H Gelb
Journal:  Biochemistry       Date:  1992-04-21       Impact factor: 3.162

6.  Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.

Authors:  K Suguna; E A Padlan; R Bott; J Boger; K D Parris; D R Davies
Journal:  Proteins       Date:  1992-07

7.  X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.

Authors:  C G Dealwis; C Frazao; M Badasso; J B Cooper; I J Tickle; H Driessen; T L Blundell; K Murakami; H Miyazaki; J Sueiras-Diaz
Journal:  J Mol Biol       Date:  1994-02-11       Impact factor: 5.469

8.  X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors.

Authors:  J Cooper; W Quail; C Frazao; S I Foundling; T L Blundell; C Humblet; E A Lunney; W T Lowther; B M Dunn
Journal:  Biochemistry       Date:  1992-09-08       Impact factor: 3.162

9.  Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.

Authors:  B Veerapandian; J B Cooper; A Sali; T L Blundell; R L Rosati; B W Dominy; D B Damon; D J Hoover
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

10.  X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.

Authors:  D Bailey; J B Cooper; B Veerapandian; T L Blundell; B Atrash; D M Jones; M Szelke
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

View more
  6 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Influence of conformation on the representation of small flexible molecules at low resolution: alignment of endothiapepsin ligands.

Authors:  Laurence Leherte; Nathalie Meurice; Daniel P Vercauteren
Journal:  J Comput Aided Mol Des       Date:  2005-11-16       Impact factor: 3.686

3.  The catalytic mechanism of an aspartic proteinase explored with neutron and X-ray diffraction.

Authors:  Leighton Coates; Han-Fang Tuan; Stephen Tomanicek; Andrey Kovalevsky; Marat Mustyakimov; Peter Erskine; Jon Cooper
Journal:  J Am Chem Soc       Date:  2008-05-15       Impact factor: 15.419

4.  X-ray, neutron and NMR studies of the catalytic mechanism of aspartic proteinases.

Authors:  Leighton Coates; Peter T Erskine; Sanjay Mall; Raj Gill; Steve P Wood; Dean A A Myles; Jonathan B Cooper
Journal:  Eur Biophys J       Date:  2006-05-04       Impact factor: 1.733

5.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

6.  Atomic resolution analysis of the catalytic site of an aspartic proteinase and an unexpected mode of binding by short peptides.

Authors:  Peter T Erskine; Leighton Coates; Sanjay Mall; Raj S Gill; Steve P Wood; Dean A A Myles; Jon B Cooper
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.